CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling
Author
AK Murugan
B Guerra
+24Â more
DW Litchfield
E Silva-Pavez
F Bray
I Bracho-Valdes
J Aparicio
J Huang
J Pallares
J Worthmuller
JLF Teh
M Garg
O Filhol
RA Heller-Harrison
RA Shuford
RL Siegel
S Bates
S Ghanaatgar-Kasbi
S Sridharan
SR Edwards
ST Stengel
SY Sun
W Wang
X Lu
Y Liu
Y Xiao
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Targeting activated PI3K/mTOR signaling overcomes acquired resistance to CDK4/6-based therapies in preclinical models of hormone receptor-positive breast cancer
Author
A Bardia
A Dhakal
+51Â more
A Min
A Provenzano
Alex Gaither
C Yang
CJ Sherr
DA Yardley
Dennis J. Slamon
DJ Slamon
Dylan Conklin
Emmanuelle DiTomaso
EY Chen
F Andre
Faye Su
GW Sledge Jr
IE Krop
J Baselga
JLF Teh
JN Mills
Kevin Chau
Kristine Rose
L Formisano
L Malorni
M Sabbah
Martina S. J. McDermott
MT Herrera-Abreu
N O’Brien
NA O’Brien
Naveen Babbar
NC Turner
Neil A. O’Brien
NP Pavletich
OW Prall
P du Rusquec
R de Leeuw
Raul Ayala
Ronald Linnartz
RS Finn
RS Finn
RS Finn
RS Finn
S Kim
SA Hurvitz
Samit Hirawat
Sara A. Hurvitz
SB Kim
SJ Isakoff
SR Vora
Suruchi Salgar
Tong Luo
VM Jansen
Z Li
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
The mTORC1 inhibitor rapamycin and the mTORC1/2 inhibitor AZD2014 impair the consolidation and persistence of contextual fear memory
Author
A Benavides-Serrato
A Bhattacharya
+78Â more
AH Babayan
AT Jones
AY Choo
B Basu
B Desgranges
B Zhao
BPP Lay
CA Hoeffer
CC Thoreen
CJ Rodriguez-Ortiz
CM Drion
D Lana
DD Sarbassov
DM Sabatini
DW Lamming
EM Glover
ER Murray
FM Freeman
GM Gafford
H Zhong
HP Davis
I Izquierdo
J Blundell
J Kahn
J Neasta
J Quevedo
JC Myskiw
JG Supko
JI Rossato
JL Banko
JL McGaugh
JLF Teh
K Yu
KM Lattal
L Slipczuk
L Stoica
L Sui
LB Flexner
LR Pearce
MD Antion
ME Feldman
MH James
MH Milekic
N Angliker
N Aslam
N Honcharik
N Meiri
P Bekinschtein
P Bekinschtein
P Bekinschtein
P Bekinschtein
P Curzon
PE MacCallum
PF Jobim
PF Jobim
PJ Hernandez
PJ Zhu
PK Dash
R Bourtchouladze
RA Saxton
RG Parsons
RJ Kelleher 3rd
RR Pena
S Sengupta
SI Arriola Apelo
SI Arriola Apelo
SM Guichard
T Abel
T Powles
T Sun
TA Werfel
TJ Ryan
TN Huynh
TN Huynh
W Cai
W Huang
WS Sossin
Y Bottiger
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Pre-clinical modeling of cutaneous melanoma
Author
A Busse
A Elkrief
+88Â more
A Kaur
A Kaur
A Mehta
A Raza
A Roesch
A Rogiers
A Sharma
A Viros
AF Silver
AL Harris
B Murekatete
BO Einarsdottir
C Atay
C Chang
CA Whipple
CM Johannessen
CP Khoo
D Dankort
D Fang
DJ Konieczkowski
DZ Chang
E Hirata
E Hodis
E Lazar-Molnar
E Perez-Guijarro
E Quintana
EE Patton
ES Park
EV Sviderskaya
G Moriceau
GM Fischer
H Jespersen
H Schmidberger
HH Peng
J Bhadury
J Friedrich
J Liu
J Tsai
J Villanueva
J Wang
JLF Teh
JS Duncan
K Boisvert-Adamo
K Noma
K Satyamoorthy
K Zitzmann
KM Tveit
L Jerby-Arnon
L Lugini
LK Smith
M Brenner
M Eskandarpour
M Fallahi-Sichani
M Gola
M Neagu
M Schreuer
MJ Hendrix
ML Mancianti
MS Brady
N Tonomura
NY Frank
OC Velazquez
OK Mirzoeva
P Valverde
PA Possik
PM Lacal
R Buttner
R Dummer
R Nazarian
R Somasundaram
RA Johnpulle
RM White
RW Jenkins
S Chen
S Ghosh
S Loffek
SE Zabierowski
SF Cramer
SM Shaffer
SY Sun
T Redmer
TH Nasti
U Graeven
VW Rebecca
WM Klein
X Wan
YC Tung
Z Hu
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref